Related Experiment Video
Updated: May 29, 2026

Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs
Published on: March 31, 2023
Oral administration of dopamine boosts anti-Vibrio immunity in shrimp through Dorsal pathway activation
Zi-Ang Wang1, Shun Liu1, Zexu Zhao1
1State Key Laboratory of Biocontrol, Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), China-ASEAN Belt and Road Joint Laboratory on Mariculture Technology, Institute of Aquatic Economic Animals and Guangdong Province Key Laboratory of Aquatic Economic Animals, School of Life Sciences, Sun Yat-sen University, Guangzhou, PR China.
Abstract:
Dopamine is a key neurotransmitter regulating diverse physiological processes, and has been increasingly recognized as an important player in immune responses. In this study, we investigated whether dietary administration of dopamine could enhance immune defense and confer protection against vibriosis in Pacific white shrimp Penaeus vannamei. Shrimp fed with dopamine exhibited significantly upregulated expression of diverse immune effector genes, including antimicrobial peptides, C-type lectins, polyphenoloxidases, and lysozymes. Dopamine treatment also enhanced hemocyte phagocytic activity against Vibrio parahaemolyticus and increased locomotor activity. Mechanistically, dopamine activated the Dorsal signaling pathway, as evidenced by elevated Dorsal phosphorylation and nuclear translocation in hemocytes. Consequently, dopamine-fed shrimp showed significantly reduced mortality and lower bacterial loads upon V. parahaemolyticus challenge. These findings demonstrate that dietary dopamine administration enhances both humoral and cellular immunity in shrimp through Dorsal pathway activation, leading to improved resistance against vibriosis. This study provides a foundation for developing dopamine-based immunostimulatory strategies for disease management in shrimp aquaculture.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
